Illumina Signs Master Supply Agreement with LabCorp
Illumina (NASDAQ: ILMN) today announced it has entered into a
multi-year supply agreement with Laboratory Corporation of America®
Holdings (LabCorp®) (NYSE: LH). The agreement gives LabCorp expanded
rights to use Illumina next-generation sequencing (NGS) and microarray
equipment and supplies to develop, validate and introduce
laboratory-developed tests to clinicians in the United States and Canada.